{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:56:26Z","timestamp":1791327386412,"version":"4.3.1"},"reference-count":98,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22007086"],"award-info":[{"award-number":["22007086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81903623"],"award-info":[{"award-number":["81903623"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M652586"],"award-info":[{"award-number":["2019M652586"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2020M670083ZX"],"award-info":[{"award-number":["2020M670083ZX"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.phrs.2021.105930","type":"journal-article","created":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T20:53:28Z","timestamp":1633640008000},"page":"105930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The role of MOZ\/KAT6A in hematological malignancies and advances in MOZ\/KAT6A inhibitors"],"prefix":"10.1016","volume":"174","author":[{"given":"Jingtian","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moran","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-1213","authenticated-orcid":false,"given":"Yongfang","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6363-5431","authenticated-orcid":false,"given":"Yongtao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2021.105930_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0168-9525(99)01971-X","article-title":"DNA hypermethylation in tumorigenesis: epigenetics joins genetics","volume":"16","author":"Baylin","year":"2000","journal-title":"Trends Genet.: TIG"},{"issue":"6990","key":"10.1016\/j.phrs.2021.105930_bib2","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2021.105930_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/ng1089","article-title":"Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals","volume":"33","author":"Jaenisch","year":"2003","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.phrs.2021.105930_bib4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s12185-017-2300-7","article-title":"The DNA damage response pathway in normal hematopoiesis and malignancies","volume":"106","author":"Delia","year":"2017","journal-title":"Int. J. Hematol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105930_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41568-020-0245-2","article-title":"Bone marrow niches in haematological malignancies","volume":"20","author":"Mendez-Ferrer","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phrs.2021.105930_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4939-8751-1_5","article-title":"Epigenetics in hematological malignancies","volume":"1856","author":"Cruz-Rodriguez","year":"2018","journal-title":"Methods Mol. Biol. (Clifton, N. J.)"},{"issue":"10","key":"10.1016\/j.phrs.2021.105930_bib7","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/nrg.2016.93","article-title":"Targeting the cancer epigenome for therapy","volume":"17","author":"Jones","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.phrs.2021.105930_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/ncomms9856","article-title":"Histone H1-mediated epigenetic regulation controls germline stem cell self-renewal by modulating H4K16 acetylation","volume":"6","author":"Sun","year":"2015","journal-title":"Nat. Commun."},{"issue":"5588","key":"10.1016\/j.phrs.2021.105930_bib9","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1126\/science.1074200","article-title":"Molecular biology: chromatin higher order folding: Wrapping up transcription","volume":"297","author":"Horn","year":"2002","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.phrs.2021.105930_bib10","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0092-8674(04)00044-3","article-title":"The nucleosome: from genomic organization to genomic regulation","volume":"116","author":"Khorasanizadeh","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.phrs.2021.105930_bib11","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2007.01.015","article-title":"The role of chromatin during transcription","volume":"128","author":"Li","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.phrs.2021.105930_bib12","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0959-437X(02)00279-4","article-title":"Histone modifications in transcriptional regulation","volume":"12","author":"Berger","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"issue":"1","key":"10.1016\/j.phrs.2021.105930_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1119(99)00405-9","article-title":"Role of covalent modifications of histones in regulating gene expression","volume":"240","author":"Spencer","year":"1999","journal-title":"Gene"},{"issue":"6765","key":"10.1016\/j.phrs.2021.105930_bib14","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/47412","article-title":"The language of covalent histone modifications","volume":"403","author":"Strahl","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.phrs.2021.105930_bib15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/bies.10038","article-title":"Histone ubiquitination: a tagging tail unfolds?","volume":"24","author":"Jason","year":"2002","journal-title":"Bioessays"},{"issue":"4","key":"10.1016\/j.phrs.2021.105930_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2021.105930_bib17","first-page":"39","article-title":"Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials","volume":"4","author":"Cheng","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2021.105930_bib18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41467-020-20543-z","article-title":"Transcription shapes genome-wide histone acetylation patterns","volume":"12","author":"Martin","year":"2021","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2021.105930_bib19","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00405-012-2275-1","article-title":"High expression levels of COX-2 and P300 are associated with unfavorable survival in laryngeal squamous cell carcinoma","volume":"270","author":"Chen","year":"2013","journal-title":"Eur. Arch. Oto-Rhino-Laryngol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105930_bib20","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2353\/ajpath.2009.080874","article-title":"Global levels of histone modifications predict prognosis in different cancers","volume":"174","author":"Seligson","year":"2009","journal-title":"Am. J. Pathol."},{"issue":"37","key":"10.1016\/j.phrs.2021.105930_bib21","doi-asserted-by":"crossref","first-page":"5395","DOI":"10.1038\/sj.onc.1210608","article-title":"The MYST family of histone acetyltransferases and their intimate links to cancer","volume":"26","author":"Avvakumov","year":"2007","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.phrs.2021.105930_bib22","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1101\/gad.1382606","article-title":"Monocytic leukemia zinc finger protein is essential for the development of long-term reconstituting hematopoietic stem cells","volume":"20","author":"Thomas","year":"2006","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.phrs.2021.105930_bib23","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1101\/gad.1393106","article-title":"MOZ is essential for maintenance of hematopoietic stem cells","volume":"20","author":"Katsumoto","year":"2006","journal-title":"Genes Dev."},{"issue":"20","key":"10.1016\/j.phrs.2021.105930_bib24","doi-asserted-by":"crossref","first-page":"4866","DOI":"10.1182\/blood-2008-04-152017","article-title":"The histone acetyl transferase activity of monocytic leukemia zinc finger is critical for the proliferation of hematopoietic precursors","volume":"113","author":"Perez-Campo","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.phrs.2021.105930_bib25","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/sj.leu.2404930","article-title":"NCOA3, a new fusion partner for MOZ\/MYST3 in M5 acute myeloid leukemia","volume":"22","author":"Esteyries","year":"2008","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.phrs.2021.105930_bib26","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.leu.2400882","article-title":"Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16)","volume":"11","author":"Giles","year":"1997","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.phrs.2021.105930_bib27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng0996-33","article-title":"The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein","volume":"14","author":"Borrow","year":"1996","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.phrs.2021.105930_bib28","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO;2-2","article-title":"MOZ is fused to p300 in an acute monocytic leukemia with t(8;22)","volume":"28","author":"Chaffanet","year":"2000","journal-title":"Genes, Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.phrs.2021.105930_bib29","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood.V91.9.3127","article-title":"A novel fusion between MOZ and the nuclear receptor coactivator TIF2 in acute myeloid leukemia","volume":"91","author":"Carapeti","year":"1998","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.phrs.2021.105930_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/gcc.10172","article-title":"Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11)","volume":"36","author":"Imamura","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"37","key":"10.1016\/j.phrs.2021.105930_bib31","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1038\/sj.onc.1210609","article-title":"MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"issue":"24","key":"10.1016\/j.phrs.2021.105930_bib32","doi-asserted-by":"crossref","first-page":"7184","DOI":"10.1093\/emboj\/20.24.7184","article-title":"Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein","volume":"20","author":"Kitabayashi","year":"2001","journal-title":"Embo J."},{"key":"10.1016\/j.phrs.2021.105930_bib33","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.isci.2018.12.016","article-title":"MOZ forms an autoregulatory feedback loop with miR-223 in AML and monocyte\/macrophage development","volume":"11","author":"Jiang","year":"2019","journal-title":"Iscience"},{"key":"10.1016\/j.phrs.2021.105930_bib34","first-page":"643","volume":"Vol. 33","author":"Varol","year":"2015"},{"issue":"3","key":"10.1016\/j.phrs.2021.105930_bib35","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.onc.1204114","article-title":"The monocytic leukemia zinc finger protein MOZ is is histone acetyltransferase","volume":"20","author":"Champagne","year":"2001","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.phrs.2021.105930_bib36","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1002\/jcp.24617","article-title":"The MOZ histone acetyltransferase in epigenetic signaling and disease","volume":"229","author":"Carlson","year":"2014","journal-title":"J. Cell. Physiol."},{"issue":"40","key":"10.1016\/j.phrs.2021.105930_bib37","doi-asserted-by":"crossref","first-page":"28528","DOI":"10.1074\/jbc.274.40.28528","article-title":"Identification of a human histone acetyltransferase related to monocytic leukemia zinc finger protein","volume":"274","author":"Champagne","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2021.105930_bib38","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1242\/dev.127.12.2537","article-title":"Querkopf, a MYST family histone acetyltransferase, is required for normal cerebral cortex development","volume":"127","author":"Thomas","year":"2000","journal-title":"Dev. (Camb., Engl. )"},{"issue":"14","key":"10.1016\/j.phrs.2021.105930_bib39","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1128\/MCB.00055-16","article-title":"Regulation of KAT6 acetyltransferases and their roles in cell cycle progression, stem cell maintenance, and human disease","volume":"36","author":"Huan","year":"2016","journal-title":"Mol. Cell. Biol."},{"issue":"8","key":"10.1016\/j.phrs.2021.105930_bib40","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.bbamcr.2015.04.014","article-title":"MOZ and MORF acetyltransferases: Molecular interaction, animal development and human disease","volume":"1853","author":"Yang","year":"2015","journal-title":"Biochim. Biophys. Acta-Mol. Cell Res."},{"issue":"7717","key":"10.1016\/j.phrs.2021.105930_bib41","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41586-018-0387-5","article-title":"Inhibitors of histone acetyltransferases KAT6A\/B induce senescence and arrest tumour growth","volume":"560","author":"Baell","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2021.105930_bib42","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/7852742","article-title":"The kat in the HAT: the histone acetyl transferase Kat6b (MYST4) Is downregulated in murine macrophages in response to LPS","volume":"2018","author":"Shukla","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"2","key":"10.1016\/j.phrs.2021.105930_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(00)80986-1","article-title":"AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis","volume":"84","author":"Okuda","year":"1996","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.phrs.2021.105930_bib44","doi-asserted-by":"crossref","first-page":"3444","DOI":"10.1073\/pnas.93.8.3444","article-title":"Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis","volume":"93","author":"Wang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.phrs.2021.105930_bib45","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1182\/blood-2004-08-3280","article-title":"Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype","volume":"106","author":"Growney","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.phrs.2021.105930_bib46","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nm997","article-title":"AML-1 is required for megakaryocytic maturation and lymphocytic differentiation, but not for maintenance of hematopoietic stem cells in adult hematopoiesis","volume":"10","author":"Ichikawa","year":"2004","journal-title":"Nat. Med."},{"issue":"22","key":"10.1016\/j.phrs.2021.105930_bib47","doi-asserted-by":"crossref","first-page":"12359","DOI":"10.1073\/pnas.93.22.12359","article-title":"Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta","volume":"93","author":"Sasaki","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.phrs.2021.105930_bib48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0092-8674(00)81389-6","article-title":"The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo","volume":"87","author":"Wang","year":"1996","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2021.105930_bib49","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ng.2007.7","article-title":"PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis","volume":"40","author":"Huang","year":"2008","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.phrs.2021.105930_bib50","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ng1361","article-title":"Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1","volume":"36","author":"Rosenbauer","year":"2004","journal-title":"Nat. Genet."},{"issue":"50","key":"10.1016\/j.phrs.2021.105930_bib51","doi-asserted-by":"crossref","first-page":"36603","DOI":"10.1074\/jbc.M705812200","article-title":"The human monocytic leukemia zinc finger histone acetyltransferase domain contains DNA-binding activity implicated in chromatin targeting","volume":"282","author":"Holbert","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2021.105930_bib52","doi-asserted-by":"crossref","first-page":"696","DOI":"10.4161\/cc.6.6.4013","article-title":"The diverse biological roles of MYST histone acetyltransferase family proteins","volume":"6","author":"Thomas","year":"2007","journal-title":"Cell Cycle"},{"issue":"10","key":"10.1016\/j.phrs.2021.105930_bib53","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/bies.201800078","article-title":"Histone lysine and genomic targets of histone acetyltransferases in mammals","volume":"40","author":"Voss","year":"2018","journal-title":"Bioessays"},{"issue":"22","key":"10.1016\/j.phrs.2021.105930_bib54","doi-asserted-by":"crossref","first-page":"6828","DOI":"10.1128\/MCB.01297-08","article-title":"Molecular architecture of quartet MOZ\/MORF histone acetyltransferase complexes","volume":"28","author":"Ullah","year":"2008","journal-title":"Mol. Cell. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2021.105930_bib55","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.jmb.2012.10.004","article-title":"Tandem PHD fingers of MORF\/MOZ acetyltransferases display selectivity for acetylated histone H3 and are required for the association with chromatin","volume":"424","author":"Ali","year":"2012","journal-title":"J. Mol. Biol."},{"issue":"12","key":"10.1016\/j.phrs.2021.105930_bib56","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1101\/gad.188359.112","article-title":"Combinatorial readout of unmodified H3R2 and acetylated H3K14 by the tandem PHD finger of MOZ reveals a regulatory mechanism for HOXA9 transcription","volume":"26","author":"Qiu","year":"2012","journal-title":"Genes Dev."},{"issue":"4","key":"10.1016\/j.phrs.2021.105930_bib57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nrg2752","article-title":"Chromatin structure and the inheritance of epigenetic information","volume":"11","author":"Margueron","year":"2010","journal-title":"Nat. Rev. Genet."},{"issue":"17","key":"10.1016\/j.phrs.2021.105930_bib58","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/sj.onc.1205367","article-title":"MOZ and MORF histone acetyltransferases interact with the Runt-domain transcription factor Runx2","volume":"21","author":"Pelletier","year":"2002","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.phrs.2021.105930_bib59","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1007\/s00277-019-03637-7","article-title":"Acute myeloid leukemia with t(8;16)(p11.2;p13.3)\/KAT6A-CREBBP in adults","volume":"98","author":"Xie","year":"2019","journal-title":"Ann. Hematol."},{"issue":"3","key":"10.1016\/j.phrs.2021.105930_bib60","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1535-6108(03)00051-5","article-title":"MOZ-TIF2-induced acute myeloid leukemia requires the MOZ nucleosome binding motif and TIF2-mediated recruitment of CBP","volume":"3","author":"Deguchi","year":"2003","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.phrs.2021.105930_bib61","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.ccr.2004.10.015","article-title":"MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors","volume":"6","author":"Huntly","year":"2004","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.phrs.2021.105930_bib62","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molcel.2005.12.007","article-title":"ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation","volume":"21","author":"Doyon","year":"2006","journal-title":"Mol. Cell"},{"issue":"7","key":"10.1016\/j.phrs.2021.105930_bib63","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/nrm1960","article-title":"Reading protein modifications with interaction domains","volume":"7","author":"Seet","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105930_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(00)01449-6","article-title":"The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation?","volume":"473","author":"Stec","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2021.105930_bib65","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2164-7-6","article-title":"The Epc-N domain: a predicted protein-protein interaction domain found in select chromatin associated proteins","volume":"7","author":"Perry","year":"2006","journal-title":"BMC Genom."},{"issue":"5","key":"10.1016\/j.phrs.2021.105930_bib66","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.biocel.2004.09.008","article-title":"Function of the ING family of PHD proteins in cancer","volume":"37","author":"Gong","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.phrs.2021.105930_bib67","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/prot.22140","article-title":"The crystal structure of the ING5 PHD finger in complex with an H3K4me3 histone peptide","volume":"72","author":"Champagne","year":"2008","journal-title":"Proteins-Struct. Funct. Bioinforma."},{"issue":"10","key":"10.1016\/j.phrs.2021.105930_bib68","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1073\/pnas.1300490110","article-title":"MOZ increases p53 acetylation and premature senescence through its complex formation with PML","volume":"110","author":"Rokudai","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2021.105930_bib69","first-page":"1","article-title":"Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.phrs.2021.105930_bib70","first-page":"23","article-title":"MOZ fusion proteins in acute myeloid leukaemia","volume":"73","author":"Troke","year":"2006","journal-title":"Transcription"},{"issue":"12","key":"10.1016\/j.phrs.2021.105930_bib71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3390\/cells8121526","article-title":"Tumor-associated macrophages in hematologic malignancies: new insights and targeted therapies","volume":"8","author":"Petty","year":"2019","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.phrs.2021.105930_bib72","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1128\/MCB.25.3.988-1002.2005","article-title":"MOZ-TIF2 inhibits transcription by nuclear receptors and p53 by impairment of CBP function","volume":"25","author":"Kindle","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"25","key":"10.1016\/j.phrs.2021.105930_bib73","doi-asserted-by":"crossref","first-page":"17124","DOI":"10.1074\/jbc.M602633200","article-title":"MOZ-TIF2 alters cofactor recruitment and histone modification at the RAR beta 2 promoter - differential effects of MOZ fusion proteins on CBP- AND MOZ-dependent activators","volume":"281","author":"Collins","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2021.105930_bib74","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nm.2122","article-title":"PU.1-mediated upregulation of CSF1R is crucial for leukemia stem cell potential induced by MOZ-TIF2","volume":"16","author":"Aikawa","year":"2010","journal-title":"Nat. Med."},{"issue":"6","key":"10.1016\/j.phrs.2021.105930_bib75","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/stem.1606","article-title":"MOZ-mediated repression of p16(INK4a) is critical for the self-renewal of neural and hematopoietic stem cells","volume":"32","author":"Perez-Campo","year":"2014","journal-title":"Stem Cells"},{"issue":"47","key":"10.1016\/j.phrs.2021.105930_bib76","doi-asserted-by":"crossref","first-page":"5807","DOI":"10.1038\/onc.2015.33","article-title":"MOZ (MYST3, KAT6A) inhibits senescence via the INK4A-ARF pathway","volume":"34","author":"Sheikh","year":"2015","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.phrs.2021.105930_bib77","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1182\/blood-2014-08-594655","article-title":"MOZ regulates B-cell progenitors and, consequently, Moz haploinsufficiency dramatically retards MYC-induced lymphoma development","volume":"125","author":"Sheikh","year":"2015","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.phrs.2021.105930_bib78","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1535-6108(04)00022-4","article-title":"Loss of CBP causes T cell lymphomagenesis in synergy with p27(Kip1) insufficiency","volume":"5","author":"Kang-Decker","year":"2004","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.phrs.2021.105930_bib79","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.exphem.2015.12.006","article-title":"Expression of the MOZ-TIF2 oncoprotein in mice represses senescence","volume":"44","author":"Largeot","year":"2016","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105930_bib80","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1074\/jbc.M805101200","article-title":"Monocytic leukemia zinc finger (MOZ) Interacts with p53 to Induce p21 expression and cell-cycle arrest","volume":"284","author":"Rokudai","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2021.105930_bib81","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/imm.12072","article-title":"The MYSTerious MOZ, a histone acetyltransferase with a key role in haematopoiesis","volume":"139","author":"Perez-Campo","year":"2013","journal-title":"Immunology"},{"issue":"19","key":"10.1016\/j.phrs.2021.105930_bib82","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2015-10-676072","article-title":"MOZ (KAT6A) is essential for the maintenance of classically defined adult hematopoietic stem cells","volume":"128","author":"Sheikh","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.phrs.2021.105930_bib83","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1093\/nar\/gkg401","article-title":"Transcriptional regulation of the human MIP-1 alpha promoter by RUNX1 and MOZ","volume":"31","author":"Bristow","year":"2003","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.phrs.2021.105930_bib84","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cell.2005.08.020","article-title":"Core transcriptional regulatory circuitry in human embryonic stem cells","volume":"122","author":"Boyer","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2021.105930_bib85","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.exphem.2016.10.006","article-title":"MOZ and BMI1 act synergistically to maintain hematopoietic stem cells","volume":"47","author":"Sheikh","year":"2017","journal-title":"Exp. Hematol."},{"issue":"1","key":"10.1016\/j.phrs.2021.105930_bib86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/leu.2008.257","article-title":"Genome profiling of acute myelomonocytic leukemia: alteration of the MYB locus in MYST3-linked cases","volume":"23","author":"Murati","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.phrs.2021.105930_bib87","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.devcel.2009.10.006","article-title":"Moz and retinoic acid coordinately regulate H3K9 acetylation, Hox gene expression, and segment identity","volume":"17","author":"Voss","year":"2009","journal-title":"Dev. Cell"},{"issue":"10","key":"10.1016\/j.phrs.2021.105930_bib88","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1177\/1087057111421631","article-title":"An efficient high-throughput screening method for MYST family acetyltransferases, a new class of epigenetic drug targets","volume":"16","author":"Falk","year":"2011","journal-title":"J. Biomol. Screen."},{"issue":"15","key":"10.1016\/j.phrs.2021.105930_bib89","doi-asserted-by":"crossref","first-page":"7146","DOI":"10.1021\/acs.jmedchem.9b00665","article-title":"Discovery of benzoylsulfonohydrazides as potent inhibitors of the histone acetyltransferase KAT6A","volume":"62","author":"Leaver","year":"2019","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2021.105930_bib90","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1021\/acs.jmedchem.9b02071","article-title":"Discovery of acylsulfonohydrazide-derived inhibitors of the lysine acetyltransferase, KAT6A, as potent senescence-inducing anti-cancer agents","volume":"63","author":"Priebbenow","year":"2020","journal-title":"J. Med. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2021.105930_bib91","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/156802662005200304123442","article-title":"Targeting histone acetyltransferase MOZ\/KAT6A as a new avenue for hematological tumor therapy","volume":"20","author":"Zhou","year":"2020","journal-title":"Curr. Top. Med. Chem."},{"issue":"5","key":"10.1016\/j.phrs.2021.105930_bib92","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4155\/fmc-2019-0212","article-title":"Action plan for hit identification (APHID): KAT6A as a case study","volume":"12","author":"Yi","year":"2020","journal-title":"Future Med. Chem."},{"issue":"13","key":"10.1016\/j.phrs.2021.105930_bib93","first-page":"2","article-title":"First-in-class KAT6A\/KAT6B inhibitor CTx-648 (PF-9363) demonstrates potent anti-tumor activity in ER plus breast cancer with KAT6A dysregulation","volume":"81","author":"Sharma","year":"2021","journal-title":"Cancer Res."},{"issue":"7789","key":"10.1016\/j.phrs.2021.105930_bib94","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41586-019-1835-6","article-title":"HBO1 is required for the maintenance of leukaemia stem cells","volume":"577","author":"MacPherson","year":"2020","journal-title":"Nature"},{"issue":"31","key":"10.1016\/j.phrs.2021.105930_bib95","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2174\/1568026619666190119143239","article-title":"Structure based drug design: clinically relevant HIV-1 integrase inhibitors","volume":"18","author":"Kaur","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"issue":"15","key":"10.1016\/j.phrs.2021.105930_bib96","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2174\/1568026619666190618130008","article-title":"Targeting tubulin-colchicine site for cancer therapy: inhibitors, antibody-drug conjugates and degradation agents","volume":"19","author":"Duan","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"issue":"22","key":"10.1016\/j.phrs.2021.105930_bib97","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.4155\/fmc-2019-0159","article-title":"Triazol: a privileged scaffold for proteolysis targeting chimeras","volume":"11","author":"Xia","year":"2019","journal-title":"Future Med. Chem."},{"issue":"20","key":"10.1016\/j.phrs.2021.105930_bib98","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2174\/1568026619666191011162955","article-title":"The present and future of novel protein degradation technology","volume":"19","author":"Xia","year":"2019","journal-title":"Curr. Top. Med. Chem."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821005144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661821005144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T14:42:46Z","timestamp":1762353766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661821005144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":98,"alternative-id":["S1043661821005144"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105930","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of MOZ\/KAT6A in hematological malignancies and advances in MOZ\/KAT6A inhibitors","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2021.105930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105930"}}